Research Tracker›Biomarker Atlas›Marker Pages›Anti-Thyroglobulin Antibodies

Anti-Thyroglobulin Antibodies: biomarker evidence

Anti-Thyroglobulin Antibodies appears in 1 entry of the OSMF biomarker atlas, covering Hypothyroidism. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Hypothyroidism

Where Anti-Thyroglobulin Antibodies is reported

Also listed as: Anti-Thyroglobulin

ConditionDirectionCompared againstAssociated symptomsSource
Hypothyroidism↑ elevatedautoimmune thyroiditis (Hashimoto's) patients vs healthy reference—Dwivedi et al. 2023

Frequently asked questions

In which conditions is Anti-Thyroglobulin Antibodies altered?

In the OSMF atlas Anti-Thyroglobulin Antibodies is reported in Hypothyroidism. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Anti-Thyroglobulin Antibodies?

The atlas entries for Anti-Thyroglobulin Antibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Anti-Thyroglobulin Antibodies result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Anti-Thyroglobulin Antibodies across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/anti-thyroglobulin-antibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.